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1. SUMMARY. 
There are not enough previous publications which are focused on mothers with 
well-controlled gestational diabetes mellitus (GDM) as a risk factor that 
determines the occurrence of neonatal hypoglycemia. In addition, approaches 
to blood glucose monitoring have been inconsistent and poorly defined. Our 
objective is to determine if being a newborn from a mother with well-controlled 
gestational diabetes (regardless insulin treatment) have a higher risk to develop 
hypoglycemia than a healthy newborn, using a defined and strict protocol. The 
project will take place in a regional hospital of Girona. We will recruit from 2014 
to 2015 a cohort of 623 infants born in this center without any malformation or 
any perinatal pathology or complication, selected with a consecutive sampling. 
We will record sex, ethnicity and gestational age information. We will measure 
blood glucose levels and anthropometric measurements in newborns always 
taking into account the presence of well-controlled maternal gestational 
diabetes or not. Patients will be followed up during 24 hours to determine the 
incidence of hypoglycemia. We will analyze the contribution between exposure 
factors that we have studied and the incidence of the outcome using a 
multivariate analysis. 
 
2. INTRODUCTION. 
2.1 Epidemiology. 
Hypoglycemia is the most common metabolic disorder of newborns, and 
glucose concentration is one of the most common biochemical measurement in 
the neonatal intensive care unit [18]. It has been estimated that 10% of normal 
term infants cannot maintain a plasma glucose concentration above 30 mg/dL if 
their first feeding is delayed 3-6 hours after birth [3]. The incidence of 
hypoglycemia is estimated to be 5%-15% in otherwise healthy babies [1], 
however, the incidence of hypoglycemia may increase from 3% to 29% when 
preterm newborns are included [13]. 
Gestational diabetes mellitus (GDM) is one of the most common complications 
during pregnancy. The incidence of GDM has increased over the last decades, 
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this is due to the increase of obesity, maternal type 2 diabetes mellitus and 
advanced maternal age [21]. GDM has a prevalence of 7.5%, and it is one of 
the metabolic disorders diagnosed in the mother that increase the risk of 
hypoglycemia in the newborns up to 27% compared to newborns of non 
diabetic mother and, particulary if the mother was not well-controlled during 
pregnancy. A study from Parc de Salut Mar (Barcelona) concluded that mild and 
moderate neonatal hypoglycemia were common in infants of women with GDM 
in the first day of live, although sever hypoglycemia is unusual and occurs early 
after birth [24]. Some studies have shown that the neurodevelopment outcome 
of infants of well-controlled diabetic mothers appears to be similar to that of 
normal infants. However, poorly controlled diabetes can produce development 
abnormalities in the offspring [7]. 
Macrosomia can occur in all diabetic pregnancies, but the incidence appears to 
be greater in infants born to mothers with pregestational diabetes. This is shown 
by the following studies: one of them based on a population of 3705 infants born 
to mothers with type 1 diabetes between 1998 and 2007 in Sweden, 47% of the 
infants were large for gestational age. In another study from Sweden based on 
all births in the Swedish Medical Birth Register from 1992 to 2004, infants born 
to mothers with gestational diabetes were four times more likely to be large for 
gestational age than infants born to nondiabetic mothers (15.8 versus 3.6%) [7]. 
Different risk factors exist to develope transient hypoglycemia in the neonatal 
period, which can be present during pregnancy, such as infants of mothers 
treated with beta adrenergic agents or infants of diabetic mothers (IDM) type I 
or II controlled with oral hypoglycemic agents, or infants of gestational diabetes 
mother. There are also factors that occur in the immediate postnatal period 
such as: prematurity, infants who are large (macrosoma) or small for gestational 
age (SGA), infants who require intensive care (eg, sepsis and asphyxia) or 
infants with polycythemia [3]. In a prospective study with 14168 newborns 
delivered in Tabriz Alzahra Hospital, where cases with blood glucose <50 
mg/dL were considered as hypoglycemic newborns, prevalence of neonatal 
hypoglycemia was greater in: prematurity (61,5%), IDM (13,6%), septicemia 
(9,6%), perinatal asphyxia (9,6%), stress (3,8%) and neonatal hyperinsulinism 
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(1,9%) [11]. Some reports also have shown the presence of three or more risk 
factors may increase the severity of hypoglycemic episodes [19]. 
Another study has valuated the maternal ethnic differences in the incidence of 
neonatal hypoglycemia in babies born to gestational diabetic mother and 
conclude that there is higher risk of neonatal hypoglycemia in some ethnic 
groups, specially in Pakistani women [21]. However, a study from a multiethnic 
population of Barcelona has shown that neonates born to Latin American 
women with gestational diabetes had the highest prevalence of overall and 
moderate hypoglycemic events; but severe neonatal hypoglycemia was not 
statistically different among the five ethnic groups [23]. 
Other reports, such as Cole and Peevy in 1994 found that cesarean sections 
increase the risk of hypoglycemia, while a study of the American Journal of 
Obstetrics shows outcomes against this. In addition, another study 
demonstrated an increase in the risk of neonatal hypoglycemia when weight 
gain was above the recommendations of the Institute of Medicine [13]. 
 
2.2 Definition of hypoglycemia. 
At present, it is difficult to define pathological neonatal hypoglycemia with an 
accurate value of glucose [22] and remains one of the most controversial issues 
in the scientific literature in the last decades [13]. No definition of pathologic 
hypoglycemia or guideline for treatment of low plasma glucose concentrations 
in newborns has been validated in clinical practice or assessed in prospective 
follow-up studies [1]. Koh and colleagues, in 1986 and 1992 performed a review 
of several pediatric textbooks and surveys of neonatal pediatricians to 
determine the threshold concentrations used to define hypoglycemia. In the first 
study, they identified definitions of hypoglycemia in term newborns ranging from 
18 to 45 mg/dL from textbooks and 18 to 70 mg/dL from surveys. When both 
studies were compared, they showed that the median threshold concentration 
had increased significantly between 1986 and 1992. In 1992, most pediatricians 
considered a safe blood glucose concentration to be greater than 36 mg/dL 
[12]. In 2011, the American Academy of Pediatrics (APP) noted that the 
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generally adopted level used to define neonatal hypoglycemia was less than 47 
mg/dL, and proposed an operational threshold of 45 mg/dL (2.5 mmol/L) as a 
target glucose level prior to routine feeds [3]. Other authors define 
hypoglycemia as blood glucose levels lower than 50 mg/dL, with a plasma 
glucose concentration of 60 mg/dL regarded as the lowest acceptable 
concentration during hypoglycemia treatment [8]. For this reason, there are so 
much controversial data on the epidemiology of neonatal hypoglycemia due to 
the lack of uniformity in glucose levels used to define hypoglycemia. Therefore, 
it is easy to understand the high variability in the described prevalences [21]. 
 
2.3 Problem statement. 
Neonatal hypoglycemia is a serious condition that may lead to irreversible 
neurological damage with severe consequences [2] or even death if not treated 
promptly [13]. Severe hypoglycemia in the newborn is associated with selective 
neuronal necrosis in multiple brain regions [20]. Yet, it is not known how low, 
how often, or for how long low plasma glucose concentrations must occur 
before there is irreversible neuronal damage [3] or clinical manifestations 
develop [13]. It is important to note that neurological damage can be present 
even in asymptomatic newborns [13]. Preliminary long-term data has suggested 
residual defects in approximately 35% of symptomatic and 20% of 
asymptomatic infants [17].  
The management of neonatal hypoglycemia is based on attempts to detect low 
glucose concentrations in newborns at risk and the maintenance of blood 
glucose concentrations higher than a safe level [18]. Previous publications show 
that babies in different risk groups have similar incidence of hypoglycemia, and 
episodes also occur at a similar time. This suggests that all babies at risk could 
be monitored using the same screening protocol, simplifying recommendations 
for clinical practice [19]. On the other hand, some authors had suggested that 
protocols should be individualized for each baby depending on the risk group, 
because the blood glucose measurement is invasive and painful and they did 
not consider it ethically correct to make this blood samples collections in 
otherwise well babies [19].  
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As newborns at risk of hypoglycemia are subjected to multiple painful pricks, 
another aspect to take into account is the consequences of pain or stress 
experiences. A review provides evidence that significant and long-lasting 
physiological consequences may follow painful insults during the neonatal 
period, including changes in the central nervous system and changes in the 
neuroendocrine and inmmune systems to stress at maturity [25]. 
 
2.4 Pathogenesis. 
Glucose is the main source of energy for organ function. Although all organs 
can use glucose, the human brain uses it almost exclusively as a substrate for 
energetic metabolism [20]. In the majority of healthy newborns, the frequently 
observed hypoglycemia is not related to any important problem and only reflect 
normal processes of metabolic adaptation to extrauterine life [15]. During 
pregnancy, the fetus receives a continuous nutrient supply through the placenta 
controlled by maternal metabolism with a minimal need for fetal endocrine 
regulation [20]. At birth, when the transplacental glucose supply is abruptly 
interrupted, the newborn has to adapt to a new metabolic environment of 
enteral feeding with milk, alternated with fasting periods [2]. Most healthy 
newborns are able to quickly initiate glucose production to maintain adequate 
concentrations during the fasting periods to satisfy their energetic demands. 
This occurs by means of increased plasma catecholamines, glucagon, and 
cortisol, in combination with a decrease in plasma insulin concentrations that 
promote glycogenolysis, gluconeogenesis, lipolysis, fatty acid oxidation, and 
muscle protein breakdown. Altogether, the goal of neonatal glucose 
homeostasis is to provide the brain and other vital organs with sufficient glucose 
for energy [12].  
Transient neonatal hypoglycemia is autolimited in the first 7 days after birth and 
it is a consequence of limited energetic reserves caused by excessive 
peripheral consumption, by an early depletion of energetic reserves or by an 
immaturity of the hypothalamic-pituitary system, responsible for the secretion of 
counterregulatory hormones [16]. 
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Premature infants and those with intrauterine growth retardation (IUGR) are at 
risk of developing transient hypoglycemia. Preterm infants have limited 
glycogen reserves because glycogen storage takes place primarily during the 
third trimester. In addition to that, preterm infants and those who have IUGR 
also have decreased accumulation of protein and fat. As a result, their ability to 
maintain glucose production by glycogenolysis and gluconeogenesis for more 
than short periods of fasting is limited [12].  
One of the most common causes of hypoglycemia in newborns linked to fetal 
hyperinsulinism is uncontrolled diabetes in the mother. These newborns tipically 
present symptomatic hypoglycemia within the first 4 to 6 hours after birth that is 
persistent, although other complications associated could modify the 
hypoglycemia onset. These neonates have an increased insulin production due 
to an increased sensivity of pancreatic beta cells to glucose, which can persists 
for days after birth [2]. Macrosomia is a common complication in infants born to 
diabetic mothers. These macrosomic newborns have a higher risk to develop 
hypoglycemia because of persistent hyperinsulinemia after the maternal 
glucose supply interrumption [7]. 
 
2.5 Clinical manifestations. 
Neonatal hypoglycemia can present symptoms, such as lethargy, hypotonia, 
apnea, tachypnea, weak suck, poor feeding, weak cry, jitteriness, irritability, 
hypothermia, seizures or coma [2][3], the most common symptoms being apnea 
with cianosis and lethargy [13]. This clinical presentation is very inespecific and 
variable  because many of these signs can result from other common neonatal 
disorders, including sepsis, hypocalcemia, hypothermia or intracranial 
hemorrhage [8]. However, neonatal hypoglycemia can be present in 
asymptomatic newborns, thus, this situation can aggravate the consequences 
because of a delayed diagnosis and treatment [3]. 
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2.6 Justification. 
The need to develop this study lies on the scarcity of previous publications 
regarding the risk of hypoglycemia in infants born to well-controlled gestational 
diabetic mothers. In addition, approaches to blood glucose monitoring have 
been inconsistent and poorly defined, and in many cases have used unrealiable 
screening methods to detect hypoglycemia. Furthermore, the study could 
provide a great benefit for newborns who in fact are not at risk or have a similar 
risk than a healthy newborn to develop hypoglycemia, preventing or reducing 
significantly the number of pricks. These blood glucose measurements are 
painful and can produce long-term sequelae in the newborn. On the other hand, 
a reduction of these interventions also involves some cost-savings for the 
national health system.  
The technical capacity to achieve the project is optimal since all the measures 
can be taken in an easy, inmediate and economic way. A regional hospital is 
also available where the project can be comfortably carried out. All of this justify 
the proposal to analyze the contribution of well-controlled gestational diabetes 
as a risk factor in neonatal hypoglycemia. 
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4. QUESTION. 
Is the well-controlled maternal gestational diabetes (regardless insulin 
treatment) the factor that determines the occurrence of hypoglycemia in 
newborns? 
 
5. HYPOTHESIS. 
Neonates born to mothers with well-controlled gestational diabetes have the 
same risk than neonates whose mothers do not have gestational diabetes. 
 
6. OBJECTIVES. 
6.1 Primary objective: to determine whether newborns from a mother with 
well-controlled gestational diabetes (with or without insulin treatment) have a 
higher risk to develop hypoglycemia than healthy newborns.  
6.2 Secondary objectives: 
• To determine the incidence of hypoglycemia in infants born to mothers 
with well-controlled gestational diabetes. 
• To determine the incidence of hypoglycemia in infants whose mothers do 
not have gestational diabetes. 
• To calculate the Relative Risk (RR) of hypoglycemia in infants born to 
mothers with well-controlled gestational diabetes. 
• To determine the number of newborns large for gestational age from 
mothers with well-controlled gestational diabetes. 
• To determine the number of newborns small for gestational age from 
mothers with well-controlled gestational diabetes. 
• To determine standard desviations of height and weight by gestational 
age of all newborns included in the study. 
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7. METHODS. 
 
7.1 Study design. 
Cohort study. Transversal, prospective, analytic and observational. We follow 
up the participants during 24 hours from the inclusion in the study. 
 
7.2 Participants. 
The study population will be all neonates born in a regional hospital in Girona 
between 2014 and 2015. 
7.2.1 Inclusion criteria: 
-Exposed group: healthy newborns from a well-controlled gestational 
diabetic mother (regardless insulin treatment) in the current pregnancy. 
-Non-exposed group: healthy newborns from a mother without gestational 
diabetes. 
7.2.2 Exclusion criteria: 
-Newborns with malformations of any kind. 
-Newborns with perinatal pathology like: respitatory distress, sepsis or 
metabolic diseases. 
-Newborns who required resuscitation at birth. 
-Newborns with loss of fetal wellbeing. 
-Newborns who do not complete the IAS hypoglycemia protocol (Annex I). 
-Infants born to mothers whose pregnancy was not well-controlled. 
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7.3 Sample selection. 
A consecutive non-probability sampling will be taken. The sample recruitment 
will take part in a regional hospital in Girona for 2 years, we will take all the 
neonates born in this hospital. Parents of the potential participants will be 
invited to participate in the study by signing an informed consent (Annex IV). 
Nursing staff will take the capillary glucose samples according to the IAS 
protocol (Annex I). 
 
7.4 Sample size. 
Accepting an alpha risk of 0.05 and a beta risk less than 0.2 in a two-sided test, 
567 exposed subjects and 56 in the non-exposed (623 in total) are necessary to 
recognize as statistically significant a relative risk greater than or equal to 2.5 if 
the rate of patients in the non-exposed group is 0.1. A drop out rate of 5% has 
been anticipated. The POISSON approximation. We have used the sample size 
and power calculator GRANMO. It is estimated that in the regional hospital in 
Girona we will have an approximate number of 2800 births during 2 years. 
 
7.5 Variables. 
All measures will take place in the same regional hospital where the participants 
are treated. 
7.5.1 Dependent variable (outcome): neonatal hypoglycemia. It is defined 
when blood glucose levels measured on capillary blood samples are less than 
45 mg/dL (2.5 mmol/L) [3] by the nursing staff using a glucometer. Samples 
will be taken at 1 hour after birth regardless of feeds, then before feeds at 2 
and 3 hours after birth, then at 6 hours, at 12 and 24 hours. Always using the 
neonatal hypoglycemia screening protocol of the regional hospital (Annex I). 
 
7.5.2 Independent variable: being born to a mother with gestational diabetes. 
It is defined as diabetes mellitus that is first detected during pregnancy [7] 
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through screening performed according to the protocol of the Gynecology and 
Obstetrics Service of the regional hospital. 
 
7.5.3 Covariables: 
• Sex. 
• Ethnicity. 6 ethnic groups will be categorized: Caucasian, Latin American, 
Moroccan, Subsaharan, East Asian and South-Central Asian [23]. 
• Gestational age. It is determined by the first day of the woman's last normal 
menstrual period (LMP) and this is confirmed by obstetric ultrasound in the 
Department of Gynecology and Obstetrics of the regional hospital. We 
considerate a preterm infant if was born before 37 weeks gestational age [2]. 
• Weight. We will use a digital pediatric scale that will be calibrate each day, 
and after each measurement will be checked to return to zero. The 
measurement will be performed by a nurse with newborns in decubitus 
supine position and naked. We considerate small for gestational age 
neonates whose weight at birth are <2 SD (Standard Desviation) or <3P 
(third percentile) under mean for gestational age [4]; and large for gestational 
age or macrosomic neonates whose weight at birth is higher or equal than 
97P (97th percentile) which is the equivalent to SD+2 (Standard Desviation) 
[9], based on data derived from adequate reference population, sex and 
gestational age (Annex IIa/b). 
• Height. We will use a pediatric measuring board and the measurement will 
be performed by a nurse with newborns in decubitus supine position and 
naked, it is necessary to calculate the length between the top of the skull and 
heel with maximun extension of the lower limb. 
• SD (Standard Desviation): it is estimated for weight and height based on 
the Anthropometric Growth Patterns by Dr. Carrascosa (Annex IIa/b). 
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7.6 Measure instruments.  
-Ultrasound machine Toshiba Nemio XG 
-Digital pediatric scale "Seca gmbh & Co.Kg". Modelo: 375 7021099 
-Pediatric measuring board "Chorder". Ref: HM80D 
-Glucometer "Stat Strip Xpress" TM. Ref: 4704 from "Nova Biomedical" 
-Glucometer strips "Stat Strip Xpress". Ref: 42214 from "Nova Biomedical" 
-Sterile metallic lancets from MenaLancet® 
 
7.7 Methods of data collection. 
Data will be collected directly from the medical records during the first days of 
postnatal period and will be reflected in database. Homogeneity in data 
collection must be ensured. The identification of the cohort will be performed by 
the same physician and the medical history will be checked daily to identify the 
group who meet the inclusion and exclusion criteria. 
 
8. STATISTICAL ANALYSIS. 
To analyze the contribution between exposure factors (confounding variables) 
that we have studied and the incidence of the outcome (hypoglycemia), a 
multivariate analysis will be performed using a logistic regression model.  
 
9. ETHICAL ASPECTS. 
This study is designed in accordance with the medical ethics requirements 
defined on the WMA Declaration of Helsinki of Ethical Principles for Medical 
Research Involving Human Subjects (last revision in october 2013) and it has 
been approved by the Clinical Research Ethics Committee (CEIC) of the 
Hospital Santa Caterina. The information will be confidential, guaranteeing the 
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anonymity of the patients involved in the study under the Organic Law of Data 
Protection. In addition, parents of newborns will be informed about the 
interventions (Annex III) and they must sign an informed consent (Annex IV) 
before being included in the study. 
 
10. STUDY LIMITATIONS AND BIASES. 
One of the main problems of the study is the confounding bias because the 
cause-effect relationship is difficult to control due to covariables. This limitation 
will be minimized through a multivariate analysis. Another possible limitation 
could be the lost to follow up, however, in this study the lost will be minimun 
because the subjects included will be hospitalized during the 24 hours of the 
follow up. 
 
11. WORK PLAN. 
Researchers: Cynthia Morales (CM), Antonio Sánchez (AS). The study has 
been designed in 5 phases: 
1. Coordination phase (2 months): Researchers: CM, AS. There will be 
organizational meetings of the research group with the nursing staff and the 
statistical consultant at the beginning of the project. The timeline of the study 
will be planned and the methods of data collection will be shared. Training of 
the nursing staff will take place in this period.  
2. Patient recruitment (24 months): Researchers: CM, AS. The samples and 
variables of the patients will be collected at the beginning. It is estimated 730 
days in 2 years. It is necessary to include 1 patient per day approximately to get 
to recruit the 623 participants needed in 24 months. The quality of the data will 
be checked regularly. With each patient: A) Start: consecutive samples will be 
taken from all the infants born in the hospital. B) Interview with parents: 
explanation of the purposes, questions about the check-ups during pregnancy 
and medical history of the parents, explanation of voluntary participation and 
signature of the informed consent. C) The nursing staff will perform capillary 
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glucose measurements according to protocol and weight and height will be 
calculated. D) To communicate our gratitude to the parents for their cooperation 
in the study. 
3. Data extraction and processing data base (29 months): Researchers: 
CM, AS. Collection of information about weight, height and capillary blood 
glucose measurements. Measurement management: enter information in the 
database while the project is being developed. Regularly, an analysis of data 
will be performed to control its evolution. 
4. Data analysis (9 months): Researchers: CM, AS. After the recruitment, all 
data collected will be analyzed and an analysis of the risk factors of the 
population will be done. Then, a multivariate analysis will be performed using 
logistic regression models to examine the contribution of confounding variables. 
5. Interpretation of results, writing articles and dissemination of research 
findings (6 months). Researchers: CM, AS. An interpretation of the results will 
be performed and the corresponding articles will be written. In Annex V you can 
see the timeline. 
 
12. DISSEMINATION PLAN. 
The results of this study will be discussed and presented through conference 
presentations, meetings, training sessions, journal articles, reports and other 
documents. Further applicability studies would be necessary to recognize the 
worth of a possible change of protocol. 
 
13. AVAILABLE MEANS TO CARRY OUT THE PROJECT: 
The project will take place in a regional hospital in Girona. This center will 
provide rooms for the clinical examination of newborns and basic material such 
as office furniture and stretchers. The hospital has all the necessary items, 
including the informatic equipment suitable for processing databases for the 
project development without additional cost. However, the nursing staff and the 
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disposable items, such as: lancets, glucometer, strips, gloves, gauze sponges 
and alcohol used for capillary blood samples of the non-exposed group will be 
paid by the project. 
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14. BUDGET. 
 
 
 
TOTAL AMOUNT OF AID CLAIMED 13.719,8 € 
 
 
 
 
CATEGORY QUANTITY TIME COST 
Nursing staff 3 24 months 7.200 € PERSONNEL 
COSTS 
Statistical consulting and 
analysis for study data 
1  2000 € 
SUBTOTAL         9200 € 
ITEM QUANTITY DESCRIPTION PRICE PER UNIT COST 
Glucometer 
strips 
700 U Box of 100 0,30 € 210€ 
Metallic lancet 700 U Box of 200 0,20 € 140 € 
Gauze sponges 700 U  Box of 200 0,033 € 23 € 
Alcohol 2 bottles  Bottle of 1L 2,40 € 4,8 € 
DISPOSABLE 
ITEMS 
Latex gloves  700 U  Box of 100 0,06 € 42 € 
SUBTOTAL       419,8  € 
ACTIVITY COST 
Coordination meetings 600 € 
Investigator meetings 2500 € 
TRAVEL 
COSTS 
Study promotions 1000 € 
SUBTOTAL     4100 € 
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ANNEX I. IAS HYPOGLYCEMIA PROTOCOL 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Avisar al pediatre 
 
 
 
 
 
Source: IAS (Institut 
d´Assistència Sanitària).      
LA (Lactancia Artificial);     
LM (Lactancia Materna). 
PROTOCOL D’HIPOGLICÈMIES 
IAS Abril 2013 
1ª hora 
<47 >ó= 47 
LA o LM i repetir glicèmia a l’hora 
LM o LA 
<ó= a 30 30-46 
(Asintomátic) 
1 
30 – 46 (Sintomátic) 
2ª hora 
>ó= 47 
LA/LM 
Valoració per pediatre 
-LM/LA 5-10 ml/3h 
-Perfusió 5-8mg/k/min 
-Bolo 2ml/k SGO% 
-Glicemias c/3h 
<ó= a 30 
1 
3ª hora 
1 1 
30-46 
(Asintomátic) 
30-46 
(Sintomátic) 
>47 
LA/LM Valorar 
perfusió 
>47 
* 6ª hora 
<47 
LA/LM Valorar 
perfusió 
LM o LA 
>47 
Suspendre controls 
* 
Repetir Glicemia si 
clínica o indicació 
del pediatra 
Factors de risc 
Preterme 
Baix pes 
Posterme 
Pes elevat 
Fill de diabètica 
Hipoxia perinatal 
Perdua benestar fetal 
Distres respiratori 
Clínica compatible amb hipoglicemia 
 
Protocol	  des	  de	  la	  sala	  de	  parts	  
1 
Control a las 12h y a las 24h 
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ANNEX IIa: ANTHROPOMETRIC GROWTH PATTERNS FOR BOYS 
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ANNEX IIb: ANTHROPOMETRIC GROWTH PATTERNS FOR GIRLS 
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ANNEX III: INFORMATION SHEET FOR PARTICIPANTS. 
	  
Project title: "Risk of hypoglycemia in newborns from mothers with gestational 
diabetes". 
We appreciate your cooperation in this study. Your participation is contributing 
significantly to improving the knowledge about the risk factors that affect the 
decline of glucose/sugar (hypoglycemia) in newborns. 
Purporse: We invite you to have your child participate in this research which 
main purpose is to study if maternal well-controlled gestational diabetes 
(diabetes diagnosed during pregnancy) is really a significant risk factor in the 
occurrence of hypoglycemia in the newborns. 
Description of the process: During the participation of your child in the study 
we are going to inform about the objectives of the project and we are going to 
answer any question you may have. If you decide that your child is going to 
participate, you will be asked about some questions such as check-ups during 
pregnancy and medical records of the parents. An examination will be 
performed to your child which consists in take measures of weight and height 
and a small amount of blood will be taken from your child´s heel to measure 
blood glucose. Samples will be taken at 1 hour after birth regardless of feeds, 
then before feeds at 2 and 3 hours after birth, then at 6 hours, and finally at 12 
and 24 hours. 
The risk of taking these samples is minimal, although some complications can 
appear, such as mild infection or slight bruising, but these will desappear in a 
few days, and like any invasive procedure, your child will feel some discomfort. 
In addition, we will always use sterile equipment. 
Your decision to have your child participate in this study is entirely voluntary. It 
is your choice whether to have your child participate or not. If you choose not to 
consent, all the services you and your child receive at this hospital will continue 
and nothing will change. You may also choose to change your mind later and 
stop participating, even if you agreed earlier, and the services you and/or your 
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child receives at the hospital will continue. You have the right to ask that any 
data you have supplied to that point be withdrawn or destroyed. 
To contact with the researcher you can address to: 
Cynthia Morales Álvarez 
Servicio de Pediatría de Hospital de Santa Caterina 
Carrer del Doctor Castany, s/n. Salt, Girona.  
 
The information that we collect from this research project will be kept 
confidential in accordance with the Organic Law of Data Protection (Organic 
Law 15/1999) and the data will be used exclusively for the purposes of this 
project. Information about your child that will be collected from the research will 
be put away and no-one but the researchers will be able to see it. Any 
information about your child will have a number on it instead of his/her name. 
Only the researchers will know what his/her number is and we will lock that 
information up, we will also respect the laws designed to protect biomedical 
research (14/2007) and any other that we can apply.  
According to current legislation, you have the right to be informed about the 
important data about your child´s health that we get from the 24 hours of follow 
up of the study. This information will be shared with you if you wish, but if you 
prefer not to be informed, your decision will be respected. 
To carry out this project and according to current legistlation, we ask for your 
consent. Before and after signing this document, if you have any questions you 
may ask them, even after the study has started. You will be given a copy of this 
information sheet. 
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ANNEX IV: INFORMED CONSENT.  
 
Project title: "Risk of hypoglycemia in newborns from mothers with gestational 
diabetes". 
Statement by participant: 
I have read the foregoing information, or it has been read to me. I have been 
informed about the purpose and implications of this study, the process of 
collection, storage and processing of personal data; this data will be used 
exclusively for the purposes of this project. I have had the opportunity to ask 
questions about it and any questions that I have asked have been answered to 
my satisfaction. I have understood that I can choose to change my mind later 
and stop participating and all services that I or my child receive at the hospital 
will continue without any consequence. I have been aware of the potential risks 
(if any). I consent voluntarily (without coercion) for my child to participate as a 
participant in this study. 
	  
Name of parent or guardian .................................................................................. 
........................................................... 
Name of participant ............................................................................................... 
............................................................. 
Signature of parent or guardian ..................................................... 
Date ....................................................   
                 Day/month/year 
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Statement by the researcher/person taking consent: 
I  have accurately read out the information sheet to the parent of the potential 
participant. I confirm that the parent was given an opportunity to ask questions 
about the study and all the questions asked by the parent have been answered 
correctly and to the best of my ability. I confirm that the individual has not been 
coerced into giving consent, and the consent has been given freely and 
voluntarily.  
A copy of this document has been provided to the participant. 
 
Name of Researcher.............................................................................................. 
..............................................................................................................................
Signature of Researcher ....................................................................................  
Date ....................................................   
                 Day/month/year 
 
 
 
 
REVOCATION OF CONSENT 
Name of parent or guardian .............................................................................. 
................................revokes consent for participation in the study explained 
above. 
 
Signature: ..........................................   Date ....................................................
                                                             Day/month/year 
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ANNEX IV: TIMELINE 
 
ACTIVITY PERSONNEL NOV
-DEC 
2013 
JAN-
JUN 
2014 
JUL-
DEC  
2014 
JAN-
JUN 
2015 
JUL-
DEC 
2015 
JAN-
MAY 
2016 
JUN-
SEP
2016 
OCT-
DEC 
2016 
JAN-
MAR 
2017 
Coordina-
tion 
meetings 
ALL THE 
TEAM 
         
Patient 
recruit-
ment 
CM, AS, NA          
Data 
extraction 
and 
processing 
database 
CM, SC, AS            
Data 
analysis 
CM, SC, AS          
Interpreta-
tion of 
results, 
publish 
and disse-
mination of 
research 
findings 
CM, SC          
 
 
• CM (researcher): general coordination, economic management and publications. 
• SC (statistical consultant): database control, data analysis, interpretation of results and 
publications. 
• AS (pediatrician): discussion and interpretations of results and publications. 
• NA (nursing staff): sample extractions and measurements. 
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